Replimune Group Inc

REPL.US
Healthcare · Biotechnology
5.35
-3.28 (-38.01%)
USD · NASDAQ

Company Information

Company Name
Replimune Group Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US76029N1063
CIK: 0001737953
CUSIP: 76029N106
Currency: USD
Full Time Employees: 465
Phone: 781 222 9600
Fiscal Year End: March
IPO Date: Jul 20, 2018
Description:

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that expresses an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4. The company was founded in 2015 and is headquartered in Woburn, Massachusetts.

Address:

500 Unicorn Park Drive, Woburn, MA, United States, 01801

People

Directors & Officers

Name Title Year Born
Dr. Sushil Patel Ph.D. CEO & Director 1971
Ms. Emily Luisa Hill Chief Financial Officer 1980
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D. Chief Medical Officer 1966
Mr. Philip Astley-Sparke F.S.A. Executive Chairman 1971
Mr. Andrew Schwendenman Chief Accounting Officer & Treasurer 1976
Mr. Shawn Glidden J.D. Senior VP & General Counsel NA
Mr. Camilo Garcia M.A., M.B.A. Chief Human Resource Officer NA
Mr. Paul Bullock Chief Manufacturing Officer & Framingham Site Head NA
Ms. Nina Aragam Senior Vice President of Portfolio Strategy & Program Management NA
Ms. Carolyn Trott Senior Vice President of Quality Assurance NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 02, 2026 Christopher Sarchi N/A Sale 6.50K $8.01 $52.07K
Dec 09, 2025 Kapil Dhingra N/A Sale 3.17K $10.40 $32.96K
Dec 02, 2025 Sushil Patel N/A Sale 10.00K $11.13 $111.30K
Nov 17, 2025 Christopher Sarchi N/A Sale 5.21K $9.10 $47.39K
Nov 17, 2025 Konstantinos Xynos N/A Sale 7.25K $9.10 $65.96K
Aug 15, 2025 Emily Luisa Hill N/A Sale 9.15K $5.37 $49.16K
May 20, 2025 Andrew Schwendenman N/A Sale 3.29K $8.05 $26.46K
May 20, 2025 Christopher Sarchi N/A Sale 3.75K $8.05 $30.18K
May 20, 2025 Emily Luisa Hill N/A Sale 2.54K $8.05 $20.41K
May 20, 2025 Konstantinos Xynos N/A Sale 7.95K $8.06 $64.09K
May 20, 2025 Philip Astley-Sparke N/A Sale 32.28K $8.06 $260.17K
May 20, 2025 Sushil Patel N/A Sale 25.11K $8.06 $202.35K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 11.05M Mar 31, 2026 13.16% $0.49 0.00%
T. Rowe Price Associates, Inc. 8.12M Mar 31, 2026 9.67% $0.01 -1.70%
RTW INVESTMENTS, LLC 7.36M Mar 31, 2026 8.76% $0.56 3.03%
BlackRock Inc 6.24M Mar 31, 2026 7.43% $0.00 2.79%
Suvretta Capital Management, LLC 4.22M Mar 31, 2026 5.03% $0.82 11,614.96%
State Street Corp 3.78M Mar 31, 2026 4.51% $0.00 2.41%
Vanguard Group Inc 3.78M Dec 31, 2025 4.50% $0.00 8.53%
FCPM III SERVICES BV 2.81M Mar 31, 2026 3.35% $2.97 0.00%
Vanguard Capital Management, LLC 2.76M Mar 31, 2026 3.29% $0.00 0.00%
D. E. Shaw & Co LP 2.34M Mar 31, 2026 2.78% $0.01 -9.26%
The Goldman Sachs Group Inc 2.28M Mar 31, 2026 2.71% $0.00 246.04%
Erste Asset Management GmbH 2.12M Mar 31, 2026 2.53% $0.14 0.00%
FMR Inc 2.05M Mar 31, 2026 2.44% $0.00 -31.40%
Geode Capital Management, LLC 1.80M Mar 31, 2026 2.15% $0.00 2.93%
The Toronto-Dominion Bank 1.59M Mar 31, 2026 1.90% $0.02 -28.64%
ADAR1 Capital Management LLC 1.58M Mar 31, 2026 1.89% $0.71 27.52%
Boxer Capital Management, LLC 1.18M Mar 31, 2026 1.40% $1.18 56.67%
Dimensional Fund Advisors, Inc. 1.14M Mar 31, 2026 1.36% $0.00 1.85%
EcoR1 Capital, LLC 1.00M Mar 31, 2026 1.19% $0.32 0.00%
JPMorgan Chase & Co 789.95K Mar 31, 2026 0.94% $0.00 -14.62%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 State Street® SPDR® S&P® Biotech ETF 2.74M 3.27% ▼ 2.17% Jun 30, 2026
2 iShares Russell 2000 ETF 2.09M 2.48% ▲ 0.60% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.97M 2.35% ▲ 0.00% Jun 30, 2026
4 Fidelity Select Biotechnology 1.51M 1.80% ▲ 0.00% May 31, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 861.77K 1.03% ▲ 1.15% Jun 30, 2026
6 iShares Russell 2000 Value ETF 732.43K 0.87% ▼ 0.69% Jun 30, 2026
7 T. Rowe Price New Horizons 718.80K 0.86% ▲ 0.00% Jun 30, 2026
8 US Small-Cap Growth II Equity Comp 718.80K 0.86% ▼ 70.22% Jun 30, 2026
9 Fidelity Small Cap Index 706.93K 0.84% ▲ 0.72% Apr 30, 2026
10 Artisan International Small-Mid Investor 603.19K 0.72% ▲ 0.00% Jun 30, 2026

Financial Highlights

Market Cap: $814.27M
EBITDA: $-312.56M
Book Value: $2.01
Earnings/Share: $-3.38
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -45.03%
ROE (TTM): -107.88%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $656.55M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 83.95M
Shares Float: 59.69M
% Insiders: 256.00%
% Institutions: 9,538.60%
Short % Float: 49.86%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-98.74M
R&D
adjust
$-221.18M
Operating Income
subtotal
$-319.92M
Other / Non-Operating Items
adjust
$5.98M
Net Income
subtotal
$-313.94M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about REPL.US!